RIVA – a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trial

Overview of attention for article published in Trials, November 2018

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 blog post.

September marks Blood Cancer Awareness Month. In recognition of this, we are proud to present some of our research on blood…

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.